Warby Parker Inc.

Warby Parker Inc. (WRBY) Market Cap

Warby Parker Inc. has a market capitalization of .

No quote data available.

CEO: Neil Harris Blumenthal

Sector: Healthcare

Industry: Medical - Instruments & Supplies

IPO Date: 2021-09-29

Website: https://www.warbyparker.com

Warby Parker Inc. (WRBY) - Company Information

Market Cap: -|Sector: Healthcare

Company Profile

Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its retail stores, website, and mobile apps. As of May 16, 2022, it had 160 retail stores in the United States and Canada. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

Analyst Sentiment

76%
Strong Buy

From 13 Active Polls

1Y Forecast: $30.86

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$25

Median

$32

High Bound

$35

Average

$31

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$30.86
▲ +35.83% Upside
Low Target
$25.00
10% Risk
Median Target
$32.00
41% Mid
High Target
$35.00
54% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 WARBY PARKER INC CLASS A (WRBY) — Investment Overview

🧩 Business Model Overview

Warby Parker operates a direct-to-consumer (DTC) plus retail model for prescription eyewear. The value chain blends: (1) customer acquisition through digital and brand channels, (2) prescription capture and lens fulfillment through integrated optical workflows, (3) proprietary or partner-sourced frame and lens assortments, and (4) distribution via owned/operated logistics and retail store operations that provide trial and service. This hybrid approach is designed to reduce reliance on third-party retailers while using physical locations to improve conversion and support post-purchase services (adjustments, replacements, and fit-related support).

A key economic feature is the mix of transaction-driven orders (new glasses, sunglasses) supported by repeat and follow-on demand (replacements, lens upgrades, and periodic prescription changes). While eyewear is not subscription, a portion of customer lifetime value comes from repeat purchases driven by prescription renewal cycles and the convenience of a familiar retailer and service process.

💰 Revenue Streams & Monetisation Model

Revenue is primarily generated from the sale of prescription eyeglasses (frames plus lenses) and sunwear (sunglasses and related lens offerings). Monetisation is driven by:

  • Gross margin structure: Lens costs, frame sourcing terms, and shipping/fulfillment efficiency are the main levers.
  • Order conversion and mix: Product assortment, promotion intensity, and the mix of higher-end lens and add-on options influence profitability.
  • Channel economics: Retail stores support higher-touch experiences and service but carry fixed cost; DTC channels carry different variable costs (shipping, returns) and require efficient digital marketing.

While the business is largely transactional, monetisation improves when the company sustains favorable lens economics, controls inventory and markdown risk, and achieves operating leverage as demand stabilizes across channels.

🧠 Competitive Advantages & Market Positioning

The moat profile is mixed: eyewear does not have strong, software-like switching costs, and network effects are limited. However, Warby Parker can still sustain an advantage through cost and execution moats and service-enabled retention.

  • Cost advantages (scale + sourcing + fulfillment): Competitors often differ in how they procure frames/lenses and how they manage distribution. Warby Parker’s scale in DTC distribution and its operational playbook can support better unit economics through logistics efficiency, tighter inventory planning, and more disciplined promotion.
  • Service and experience as a retention lever: Fit, adjustments, and replacements can reduce friction and improve customer satisfaction, supporting repeat purchasing over the prescription cycle.
  • Omnichannel throughput: Retail provides a conversion and service backstop, while DTC provides margin and customer data advantages. Coordinating assortment and fulfillment across channels can be operationally difficult for smaller players.

Competitive benchmarking:

  • Zenni Optical: Strong in low-cost online pricing; typically competes on price and low-friction e-commerce.
  • EyeBuyDirect: DTC online glasses retailer; competes using catalog breadth and digital demand generation.
  • LensCrafters (Luxottica group): Brick-and-mortar optical chain; competes through store footprint and third-party lab/network arrangements.

Warby Parker’s positioning differs by targeting a value-conscious customer segment while retaining a service-forward omnichannel model—seeking to balance price competitiveness with a controlled customer experience and operational efficiency. The competitive pressure from low-cost pure-play online retailers tends to be on price and promotions, while chains can pressure with convenience and established retail distribution.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is primarily a function of expanding addressable demand and improving unit economics rather than creating a new category. Key drivers include:

  • Ongoing prescription and eye-care demand: Eyewear purchase cycles and ongoing vision correction needs provide baseline market tailwinds.
  • Penetration of DTC channels: Continued consumer shift toward online convenience (with service supported by either digital tools or retail touchpoints).
  • Assortment expansion: Broader frame styles, lens technologies, and sunwear can increase average order value.
  • Omnichannel optimization: Better allocation of inventory and marketing spend across DTC and stores can improve conversion and reduce markdown volatility.
  • International and adjacent opportunities: Geographic expansion (where executed with disciplined cost structure) can broaden the customer base, though it increases operational complexity.

⚠ Risk Factors to Monitor

  • Price competition and promotion cycles: DTC eyewear markets can experience margin compression when low-cost players increase promotional intensity.
  • Inventory and demand forecasting risk: Product seasonality and changing consumer tastes can raise markdown risk and tie up working capital.
  • Lens and input cost volatility: Changes in lens supply economics or transportation and labor costs can affect gross margin.
  • Channel execution risk: Retail fixed-cost absorption matters; underperformance in stores can pressure consolidated profitability.
  • Regulatory and compliance considerations: Consumer protection, advertising rules, and optical prescription compliance can affect operating procedures and costs.

📊 Valuation & Market View

The market typically values eyewear retailers on sales scale and margin sustainability rather than high-growth software-like metrics. Common frameworks include:

  • EV/EBITDA and operating margin trajectory: Investors focus on the ability to convert revenue into sustainable profitability.
  • P/S (price-to-sales) for growth expectations where near-term earnings are less informative due to reinvestment and channel mix.
  • Gross margin and marketing efficiency: Drivers that influence forward profitability and risk perception.
  • Inventory turns and working capital discipline: Signals of demand quality and reduced markdown exposure.

Key variables that tend to move valuation are the company’s capacity to maintain gross margins through supply-chain execution, avoid excessive promotional pressure, and deliver operating leverage as scale and channel coordination improve.

🔍 Investment Takeaway

Warby Parker’s long-term investment case rests on a service-enabled omnichannel model paired with cost and operational execution that can help sustain unit economics in a competitive eyewear market. The structural moat is not switching-cost-driven, but it can be durable if the company continues to manage supply-chain efficiency, inventory risk, and channel economics while meeting evolving consumer expectations for convenient, supported eyewear purchases.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"WRBY reported Q1 2026 revenue of $242.4M and net income of $3.18M (EPS $0.03). YoY, revenue declined -8.9% (from $223.8M in Q1’25), while net income decreased -8.4% (from $3.47M). QoQ, revenue rose +14.4% (vs. $212.0M in Q4’25), and net income improved sharply to positive $3.18M from a net loss of -$5.95M. Profitability remains volatile across quarters: gross margin was 54.0% in Q1’26, modestly up vs. 52.4% in Q4’25, but below the 56.3% level from Q1’25. Operating income turned positive to $1.67M (operating margin +0.7%) after -3.2% in Q4’25. Net margin improved to +1.3% QoQ, but stayed below Q1’25 (+1.6%). Cash flow quality looks solid for the quarter: operating cash flow (OCF) was $24.5M and free cash flow (FCF) was $8.4M. The balance sheet shows liquidity strength (cash $288.2M; current ratio ~2.33) and manageable leverage (net debt remains negative at -$50.6M), with equity largely stable (~$375.8M). Total shareholder returns appear strong given the market’s momentum: the stock is up +74.3% over 1 year, likely driven by capital appreciation (no dividends paid; buybacks not indicated)."

Revenue Growth

Caution

Q1’26 revenue was $242.4M: +14.4% QoQ vs. Q4’25 ($212.0M) but -8.9% YoY vs. Q1’25 ($223.8M).

Profitability

Neutral

Net income improved QoQ to +$3.18M from -$5.95M, with net margin +1.3%. YoY net income fell -8.4%, and gross/net margins remain below Q1’25 levels—profitability is still choppy.

Cash Flow Quality

Good

Q1’26 OCF was $24.5M and FCF was $8.4M (positive). No dividends were paid, and buybacks were not reported as activity in the quarter.

Leverage & Balance Sheet

Good

High liquidity (cash $288.2M; current ratio ~2.33). Leverage appears manageable with negative net debt (-$50.6M) and relatively stable total assets/equity QoQ.

Shareholder Returns

Strong

Strong capital appreciation: +74.3% 1-year price change (momentum >20%). Dividend yield is 0 and no buyback impact is evident from the provided data.

Analyst Sentiment & Valuation

Neutral

Consensus target is $29.67 vs. current price $24.86, implying upside of ~19%. However, trailing valuation multiples appear inflated/unstable given quarter-to-quarter earnings volatility.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Warby Parker delivered Q1 2026 results ahead of guidance but with meaningful margin drag. Revenue rose 8.3% to $242.4M despite extreme winter disruption and ongoing category traffic softness. Adjusted gross margin fell 220 bps to 54.2% from fixed-cost deleverage (doctor headcount and occupancy), tariff costs tied to glasses, and higher lab/shipping expense, only partially offset by selective price actions and better lens mix. Adjusted SG&A improved 100 bps due to Home Try-On marketing sunset, while e-commerce was down 4.1% YoY from the Home Try-On lap; management expects low-single-digit full-year e-commerce growth as that headwind fades. The company reaffirmed full-year guidance (revenue $959M–$976M; adjusted EBITDA $117M–$119M; 130 bps EBITDA margin expansion to 12.2%). Q2 outlook calls for ~10–11% revenue growth and ~12% EBITDA margin. Upside themes are exam momentum (+30% YoY), sport launch (starting $195/$295), insurance penetration (~10% in-network), and AI glasses investments backed by Google/Samsung partnerships and a $75M reimbursement.

AI IconGrowth Catalysts

  • Exams grew 30% YoY; exam services expanded to nearly 90% of stores; retinal imaging rolled out across all active exam lanes; new tools reduced optometrist admin burden
  • Sport collection launched late April; entry into sport eyewear segment with performance polarized lenses and wrap prescription capabilities; price points starting $195 (nonprescription) and $295 (prescription)
  • Higher-margin mix continued via increased progressive lens and add-on penetration; progressives described as a key tailwind for AUR
  • E-commerce stabilization excluding Home Try-On; AI-powered Photo Booth (Virtual Try-On on product pages) plus a new personalized recommendations engine driving non-Home Try-On glasses growth
  • Insurance penetration increased: in-network ~10% penetration up from ~8% prior year; automatic out-of-network submission tool rolled out to all stores in early March improving customer submission and reimbursements

Business Development

  • Partnership with Google: shared commitment to build intelligent eyewear category; $75 million reimbursement cited to support AI glasses investment
  • Partnership with Samsung: working closely with Samsung alongside Google on intelligent eyewear
  • Sport collection partnership with leading Italian manufacturers specializing in flexible, lightweight nylon production
  • Marketing/community partners in New York Fashion Week events: Happy Medium and Fashion Fiction
  • Arch Manning featured campaigns supporting brand awareness and customer acquisition

AI IconFinancial Highlights

  • Revenue: $242.4M, +8.3% YoY; exceeded guidance
  • Adjusted EBITDA: $29.6M (12.2% of revenue), above guidance; EBITDA margin down 90 bps YoY to 12.2%
  • Adjusted gross margin: 54.2%, down 220 bps YoY; driven by fixed-expense deleverage (doctor headcount, occupancy) and tariff costs related to glasses plus higher optical lab and shipping costs
  • Adjusted SG&A: $117.1M, 48.3% of revenue, down 100 bps YoY; marketing spend declined 90 bps YoY to 11.6% of revenue due to Home Try-On sunset
  • E-commerce revenue: $63.6M, -4.1% YoY, primarily due to lapping Home Try-On (sunset end of prior year); full-year e-commerce expected to grow in low single digits as Home Try-On headwind diminishes
  • Guidance includes no revenue contribution from AI glasses (but includes known pre/post-launch operating expenses)

AI IconCapital Funding

  • Cash position: $288M at end of Q1, +$23M vs Q1 2025
  • Free cash flow: approximately $8M generated in Q1
  • Share repurchase authorization: $100M prioritized for capital flexibility
  • Credit facility: $120M expandable to $175M; undrawn except ~$4M outstanding for letters of credit

AI IconStrategy & Ops

  • Retail footprint expansion: opened 14 net new stores in Q1 vs 11 prior year period; on track for 50 stores in 2026; store openings included entry into Baton Rouge, Louisiana and expansion in 9 existing markets
  • Omnichannel/AI commerce: rolled out AI-powered Photo Booth via Virtual Try-On; launched personalized recommendations engine
  • Operational readiness for AI launch: investments in store dedicated display bays, improved acoustics, tailored digital experience; optical lab capacity expansion and upgrades to business systems for complex lens fulfillment at scale
  • Contact lens acquisition disciplined after late-year moderation; reallocating marketing spend from contacts toward glasses
  • Insurance tooling: automatic out-of-network submission tool rolled out to all stores in early March; management stated customers using the feature spend more

AI IconMarket Outlook

  • Full-year 2026 guidance reaffirmed: revenue $959M to $976M (~10% to 12% YoY growth)
  • Full-year 2026 adjusted EBITDA guidance: $117M to $119M; adjusted EBITDA margin 12.2% across the revenue range; 130 bps of expansion YoY
  • Q2 2026 guidance: revenue $235M to $238M (~10% to 11% YoY growth)
  • Q2 adjusted EBITDA: $27M to $29M; adjusted EBITDA margin ~12% at midpoint
  • Management stated gross margin expected to improve via lapping more favorable tariff dynamics year-over-year and initiatives already in flight; described early benefits starting April

AI IconRisks & Headwinds

  • Extreme winter weather and temporary store closures drove Q1 disruption; management cited twice as many store closures vs last year
  • Broader industry softness and continued weakness in category traffic and unit demand in Q1
  • Gross margin pressure: 220 bps decline YoY from deleverage in fixed expenses plus tariff costs related to glasses and increased optical lab/shipping costs
  • E-commerce impacted by Home Try-On lapping; Q1 e-commerce down 4.1% YoY with headwind expected to diminish through the year
  • Competition and category growth historically coming from price; management emphasized younger demo pressure (unemployment/student debt) and macro-driven sentiment near record lows

Q&A: Analyst Interest

  • Revenue acceleration: Management attributed annual guide acceleration to strengthening e-commerce non-Home Try-On, lapping the Home Try-On sunset, benefits from out-of-network reimbursement feature rolled to all stores, and the sport collection launch starting late April. They also cited more efficient marketing spend and expect acceleration through the year despite lapping price increases.
  • Active customer growth and stores: Management said Q1 headwinds (extreme weather driving more closures, weak sentiment) impacted customer growth, and stressed active customers are reported as trailing 12-month. They reiterated reacceleration drivers: deploying marketing spend more efficiently, shifting dollars toward glasses, improving e-com with Home Try-On headwinds abating, and insurance/exam/new launches; AI launch expected to add traffic.
  • Gross margin and tariffs (implied): Management explained the Q1 gross margin decline as cost deleverage tied to 30% exam growth and fixed occupancy/doctor compensation plus lab/store closures and recovery costs. For improvement, they cited lapping more favorable tariff rates starting April, out-of-network changes improving margin, mix toward higher-margin products, and lab efficiency initiatives.

Sentiment: MIXED

Note: This summary was synthesized by AI from the WRBY Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — Warby Parker Inc. (WRBY) Financial Profile